Tumor necrosis factor α, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver

被引:198
作者
Rüdiger, HA
Clavien, PA
机构
[1] Univ Zurich Hosp, Div Visceral & Transplantat Surg, CH-8091 Zurich, Switzerland
[2] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
关键词
D O I
10.1053/gast.2002.30304
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Apoptosis of hepatocytes is a central feature of ischemic injury in the liver. The aim of this study was to identify extracellular inducers of apoptosis in the murine ischemic liver. Methods: Involvement of tumor necrosis factor (TNF)-alpha and Fas signaling was evaluated using various knockout mice (TNF-receptor 1 [TNF-R1]-/-, Fas[lpr]-/-, and Fas ligand[gld]-/-) and wild-type mice pretreated with pentoxifylline, an inhibitor of TNF-alpha synthesis. Results: Expression of TNF-alpha was increased after ischemia and reperfusion in wild-type mice and TNF-R1-deficient mice when compared with sham-operated animals. Pentoxifylline prevented up-regulation of TNF-alpha expression. Inhibition of TNF-alpha resulted in significant decrease of serum aspartate aminotransferase levels and prolonged animal survival. Markers of apoptosis (terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nickend labeling staining, cytochrome C release, and caspase 3 activity) were consistently decreased, and animal survival was prolonged after blocking TNF-alpha. In contrast, Inhibition of Fas signaling did not alter parameters of tissue injury or apoptosis, and animal survival remained unchanged. Conclusions: We identify TNF-alpha as a crucial inducer of apoptotic cell death in the ischemic liver. A role for Fas could not be identified. These findings may lead to novel strategies to prevent ischemic injury of the liver.
引用
收藏
页码:202 / 210
页数:9
相关论文
共 55 条
  • [1] TUMOR-NECROSIS-FACTOR RECEPTOR SUPERFAMILY MEMBERS AND THEIR LIGANDS
    ARMITAGE, RJ
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (03) : 407 - 413
  • [2] Pentoxifylline selectivity inhibits tumor necrosis factor synthesis in the arterial wall
    Bernard, C
    Barnier, P
    Merval, R
    Esposito, B
    Tedgui, A
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 : S30 - S33
  • [3] Bradham CA, 1998, AM J PHYSIOL-GASTR L, V275, pG387, DOI 10.1152/ajpgi.1998.275.3.G387
  • [4] Bruck R, 1997, YALE J BIOL MED, V70, P391
  • [5] ROLE OF TUMOR NECROSIS FACTOR-ALPHA IN THE PATHOPHYSIOLOGIC ALTERATIONS AFTER HEPATIC ISCHEMIA REPERFUSION INJURY IN THE RAT
    COLLETTI, LM
    REMICK, DG
    BURTCH, GD
    KUNKEL, SL
    STRIETER, RM
    CAMPBELL, DA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (06) : 1936 - 1943
  • [6] THE PRODUCTION OF TUMOR NECROSIS FACTOR-ALPHA AND THE DEVELOPMENT OF A PULMONARY CAPILLARY INJURY FOLLOWING HEPATIC ISCHEMIA REPERFUSION
    COLLETTI, LM
    BURTCH, GD
    REMICK, DG
    KUNKEL, SL
    STRIETER, RM
    GUICE, KS
    OLDHAM, KT
    CAMPBELL, DA
    [J]. TRANSPLANTATION, 1990, 49 (02) : 268 - 272
  • [7] Colletti LM, 1996, HEPATOLOGY, V23, P506
  • [8] A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis
    Cursio, R
    Gugenheim, J
    Ricci, JE
    Crenesse, D
    Rostagno, P
    Maulon, L
    Saint-Paul, MC
    Ferrua, B
    Auberger, P
    [J]. FASEB JOURNAL, 1999, 13 (02) : 253 - 261
  • [9] In situ determination by surface chemiluminescence of temporal relationships between evolving warm ischemia-reperfusion injury in rat liver and phagocyte activation and recruitment
    Cutrìn, JC
    Boveris, A
    Zingaro, B
    Corvetti, G
    Poli, G
    [J]. HEPATOLOGY, 2000, 31 (03) : 622 - 632
  • [10] Edwards CK, 1999, ANN RHEUM DIS, V58, P73